Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $7.71 billion. The enterprise value is $6.21 billion.

Market Cap	7.71B
Enterprise Value	6.21B

Important Dates

The next estimated earnings date is Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

RVMD has 167.04 million shares outstanding. The number of shares has increased by 54.50% in one year.

Shares Outstanding	167.04M
Shares Change (YoY)	+54.50%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	2.35%
Owned by Institutions (%)	95.95%
Float	153.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	832.95
PB Ratio	4.73
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8,370.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.42, with a Debt / Equity ratio of 0.05.

Current Ratio	15.42
Quick Ratio	15.10
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,898.46

Financial Efficiency

Return on equity (ROE) is -40.73% and return on invested capital (ROIC) is -26.63%.

Return on Equity (ROE)	-40.73%
Return on Assets (ROA)	-24.95%
Return on Capital (ROIC)	-26.63%
Revenue Per Employee	$1,963
Profits Per Employee	-$1.37M
Employee Count	378
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-3.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.97% in the last 52 weeks. The beta is 1.43, so RVMD's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	+48.97%
50-Day Moving Average	43.99
200-Day Moving Average	35.68
Relative Strength Index (RSI)	63.10
Average Volume (20 Days)	730,428

Short Selling Information

The latest short interest is 16.51 million, so 9.88% of the outstanding shares have been sold short.

Short Interest	16.51M
Short Previous Month	16.84M
Short % of Shares Out	9.88%
Short % of Float	10.77%
Short Ratio (days to cover)	17.40

Income Statement

In the last 12 months, RVMD had revenue of $742,000 and -$519.21 million in losses. Loss per share was -$3.58.

Revenue	742,000
Gross Profit	-420.18M
Operating Income	-575.23M
Pretax Income	-522.73M
Net Income	-519.21M
EBITDA	-569.47M
EBIT	-575.23M
Loss Per Share	-$3.58

Balance Sheet

The company has $1.59 billion in cash and $87.41 million in debt, giving a net cash position of $1.50 billion or $9.00 per share.

Cash & Cash Equivalents	1.59B
Total Debt	87.41M
Net Cash	1.50B
Net Cash Per Share	$9.00
Equity (Book Value)	1.62B
Book Value Per Share	9.77
Working Capital	1.52B

Cash Flow

In the last 12 months, operating cash flow was -$509.79 million and capital expenditures -$10.42 million, giving a free cash flow of -$520.21 million.

Operating Cash Flow	-509.79M
Capital Expenditures	-10.42M
Free Cash Flow	-520.21M
FCF Per Share	-$3.11

Margins

Gross Margin	n/a
Operating Margin	-77,524.66%
Pretax Margin	-70,448.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-70,108.49%

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.50%
Shareholder Yield	-54.50%
Earnings Yield	-6.73%
FCF Yield	-6.74%

Analyst Forecast

The average price target for RVMD is $49.54, which is 7.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$49.54
Price Target Difference	7.28%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	120.40%
EPS Growth Forecast (5Y)	-58.34%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RVMD has an Altman Z-Score of 12.81 and a Piotroski F-Score of 2.

Altman Z-Score	12.81
Piotroski F-Score	2